Ochre Bio brings together an incredible Scientific Strategy Board

Oct 28, 2022

Ochre Bio has announced their Scientific Strategy Board. This group of brilliant minds recently spent a day together in New York, to talk through Ochre’s scientific approach and future planning.

Sangeeta Bhatia – Wilson Professor of Engineering, MIT
Chinweike Ukomadu – SVP & Head of GI Therapeutic Area Unit, Takeda
chas bountra – Pro Vice Chancellor for Innovation & Professor of Translational Medicine, Oxford University
Scott Friedman – Professor and Chief, Division of Liver Diseases, Mount Sinai
Troy Dale – Head of Strategic Partnerships Unit, Novartis
Joel Dudley – Partner at IE; Former CSO Tempus Labs
Michael Hodges – Former CMO and Head of Development, Santaris Pharmaceuticals
Leanne Hodson – Professor of Metabolic Physiology, Oxford University
Eduardo Bruno Martins – CMO, Sagimet; Former VP of Clinical Development, Allergan/Abbvie
Alex K. Shalek – Associate Professor, MIT (and long time Ochre Bio sympathiser)

Watch some of the SSB members’ comments here!